x

Mersana Therapeutics, Inc. (Nasdaq:MRSN)

Health Care/Life Sciences • Biotechnology
CIK 1442836
Company

Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592. The company was founded by Mikhail Papisov in 2001 and is headquartered in Cambridge, MA.

Address
840 Memorial Drive
Cambridge, Massachusetts 02139
Employees
123
Stock Info
Close
$0.5124
Day Range
0.4934 - 0.5280
52 Week Range
0.4625 - 6.2801
Average volume
5.04M
Short Interest
9.15M (02/14/25)
% of Float Shorted
10.67%
Market Cap
$63.86M
Revenue
$36.86M
Net Income
-$171.67M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$0.5652
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
President, Chief Executive Officer & Director
Martin H. Huber
Director
Anna Protopapas
Chairman
David M. Mott
Independent Director
Willard H. Dere
Independent Director
Lawrence M. Alleva
Independent Director
Allene M. Diaz
Independent Director
Andrew A. F. Hack
Independent Director
Kristen M. Hege
SEC filings
DateFormEvent
19 Dec, 2024 8-K
15 Nov, 2024 SC 13D/A
14 Nov, 2024 SC 13G/A
14 Nov, 2024 SC 13G/A
13 Nov, 2024 10-Q
13 Nov, 2024 8-K
29 Oct, 2024 144
29 Oct, 2024 4
15 Oct, 2024 SC 13G/A
7 Oct, 2024 144
7 Oct, 2024 4
7 Oct, 2024 4
7 Oct, 2024 4
7 Oct, 2024 4
7 Oct, 2024 4
7 Oct, 2024 144
7 Oct, 2024 144
7 Oct, 2024 144
3 Oct, 2024 4
13 Sep, 2024 4
13 Sep, 2024 144
13 Aug, 2024 10-Q
13 Aug, 2024 8-K
2 Jul, 2024 4
12 Jun, 2024 4
12 Jun, 2024 4
12 Jun, 2024 4
12 Jun, 2024 4
12 Jun, 2024 4
12 Jun, 2024 4
12 Jun, 2024 4
11 Jun, 2024 8-K
17 May, 2024 SC 13G
9 May, 2024 424B5
9 May, 2024 8-K
9 May, 2024 EFFECT
9 May, 2024 10-Q
26 Apr, 2024 ARS
26 Apr, 2024 DEFA14A
26 Apr, 2024 DEF 14A
3 Apr, 2024 4
28 Feb, 2024 8-K
28 Feb, 2024 8-K
28 Feb, 2024 424B5
28 Feb, 2024 POSASR
28 Feb, 2024 10-K
28 Feb, 2024 POS AM
16 Feb, 2024 4/A
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G
14 Feb, 2024 SC 13G
14 Feb, 2024 SC 13G/A
13 Feb, 2024 SC 13G
29 Jan, 2024 SC 13G/A
22 Jan, 2024 SC 13G/A
17 Jan, 2024 4
17 Jan, 2024 4
17 Jan, 2024 4
17 Jan, 2024 4
17 Jan, 2024 4
17 Jan, 2024 4
17 Jan, 2024 4
17 Jan, 2024 4
16 Jan, 2024 144
16 Jan, 2024 144
16 Jan, 2024 144
16 Jan, 2024 144
12 Jan, 2024 S-8
5 Jan, 2024 8-K
4 Jan, 2024 4
4 Jan, 2024 4
4 Jan, 2024 4
4 Jan, 2024 4
21 Dec, 2023 8-K
7 Nov, 2023 10-Q
7 Nov, 2023 8-K
31 Oct, 2023 8-K
27 Oct, 2023 4
4 Oct, 2023 4
4 Oct, 2023 4
4 Oct, 2023 4
4 Oct, 2023 4
4 Oct, 2023 4
13 Sep, 2023 4
13 Sep, 2023 4
12 Sep, 2023 8-K
7 Sep, 2023 4
7 Sep, 2023 3
7 Sep, 2023 4
7 Sep, 2023 4
7 Sep, 2023 4
7 Sep, 2023 4
6 Sep, 2023 8-K CEO Change
18 Aug, 2023 4
8 Aug, 2023 10-Q
8 Aug, 2023 8-K
7 Aug, 2023 SC 13G
31 Jul, 2023 3
27 Jul, 2023 SC 13G
27 Jul, 2023 8-K
6 Jul, 2023 4
6 Jul, 2023 4
6 Jul, 2023 4
6 Jul, 2023 4
6 Jul, 2023 4
15 Jun, 2023 8-K
12 Jun, 2023 4
12 Jun, 2023 4
12 Jun, 2023 4
12 Jun, 2023 4
12 Jun, 2023 4
12 Jun, 2023 4
12 Jun, 2023 4
9 Jun, 2023 8-K
9 May, 2023 8-K
9 May, 2023 S-3ASR
9 May, 2023 10-Q
28 Apr, 2023 DEF 14A
28 Apr, 2023 4
28 Apr, 2023 ARS
28 Apr, 2023 DEFA14A
14 Apr, 2023 PRE 14A
5 Apr, 2023 4
5 Apr, 2023 4
5 Apr, 2023 4
5 Apr, 2023 4
5 Apr, 2023 4
31 Mar, 2023 8-K
24 Mar, 2023 8-K
13 Mar, 2023 8-K
28 Feb, 2023 8-K
28 Feb, 2023 S-8
28 Feb, 2023 10-K
14 Feb, 2023 SC 13G
14 Feb, 2023 SC 13G/A
14 Feb, 2023 SC 13G/A
14 Feb, 2023 SC 13G/A
9 Feb, 2023 SC 13G/A
6 Feb, 2023 SC 13G/A
3 Feb, 2023 SC 13G/A
1 Feb, 2023 8-K
31 Jan, 2023 SC 13G/A
25 Jan, 2023 8-K
19 Jan, 2023 SC 13G/A
18 Jan, 2023 4
18 Jan, 2023 4
18 Jan, 2023 4
18 Jan, 2023 4
18 Jan, 2023 4
18 Jan, 2023 4
18 Jan, 2023 4
6 Jan, 2023 8-K
27 Dec, 2022 8-K
22 Dec, 2022 8-K
16 Dec, 2022 4
2 Dec, 2022 4
7 Nov, 2022 8-K
7 Nov, 2022 10-Q
7 Nov, 2022 424B5
7 Nov, 2022 8-K
6 Oct, 2022 8-K
18 Aug, 2022 4
16 Aug, 2022 8-K
8 Aug, 2022 8-K
8 Aug, 2022 10-Q
8 Aug, 2022 8-K
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 8-K
10 Jun, 2022 4
10 Jun, 2022 4
2 Jun, 2022 4
26 May, 2022 4
23 May, 2022 4
18 May, 2022 4
11 May, 2022 SC 13D/A
9 May, 2022 10-Q
9 May, 2022 8-K
29 Apr, 2022 DEFA14A
29 Apr, 2022 DEF 14A
28 Apr, 2022 4
18 Apr, 2022 PRE 14A
14 Apr, 2022 SC 13D/A
14 Apr, 2022 4
13 Apr, 2022 4
28 Feb, 2022 8-K
28 Feb, 2022 8-K
28 Feb, 2022 424B5
28 Feb, 2022 10-K
28 Feb, 2022 S-8
17 Feb, 2022 SC 13G
11 Feb, 2022 SC 13G
10 Feb, 2022 SC 13G
8 Feb, 2022 SC 13D/A
8 Feb, 2022 4
4 Feb, 2022 SC 13G/A
3 Feb, 2022 8-K
27 Jan, 2022 SC 13G
26 Jan, 2022 SC 13G/A
19 Jan, 2022 4
19 Jan, 2022 4
19 Jan, 2022 4
19 Jan, 2022 4
19 Jan, 2022 4
19 Jan, 2022 4
19 Jan, 2022 4
5 Jan, 2022 4
5 Jan, 2022 4
5 Jan, 2022 4
5 Jan, 2022 4
5 Jan, 2022 4
5 Jan, 2022 4
5 Jan, 2022 4
4 Jan, 2022 4
3 Jan, 2022 4
3 Jan, 2022 SC 13D/A
20 Dec, 2021 4
2 Dec, 2021 4
23 Nov, 2021 8-K
18 Nov, 2021 EFFECT
16 Nov, 2021 CORRESP
15 Nov, 2021 UPLOAD
9 Nov, 2021 8-K
9 Nov, 2021 S-3
9 Nov, 2021 10-Q
29 Oct, 2021 8-K
16 Sep, 2021 SC 13G
10 Sep, 2021 8-K
24 Aug, 2021 4
18 Aug, 2021 4
18 Aug, 2021 3
16 Aug, 2021 8-K
6 Aug, 2021 8-K
6 Aug, 2021 10-Q
22 Jul, 2021 4
19 Jul, 2021 4
19 Jul, 2021 4
19 Jul, 2021 4
9 Jul, 2021 4
2 Jul, 2021 4
2 Jul, 2021 4
23 Jun, 2021 4
17 Jun, 2021 8-K
15 Jun, 2021 4
15 Jun, 2021 4
15 Jun, 2021 4
15 Jun, 2021 4
15 Jun, 2021 4
15 Jun, 2021 4
3 Jun, 2021 4
24 May, 2021 4
10 May, 2021 8-K
10 May, 2021 S-8
10 May, 2021 10-Q
28 Apr, 2021 4
28 Apr, 2021 3
27 Apr, 2021 DEFA14A
27 Apr, 2021 DEF 14A
22 Apr, 2021 4
9 Apr, 2021 8-K
24 Mar, 2021 4
11 Mar, 2021 4
11 Mar, 2021 3
11 Mar, 2021 8-K
26 Feb, 2021 10-K
26 Feb, 2021 8-K
24 Feb, 2021 4
12 Feb, 2021 SC 13G
12 Feb, 2021 SC 13G/A
11 Feb, 2021 SC 13G/A
4 Feb, 2021 SC 13G
27 Jan, 2021 SC 13G/A
25 Jan, 2021 SC 13G
22 Jan, 2021 4
20 Jan, 2021 4
20 Jan, 2021 4
20 Jan, 2021 4
20 Jan, 2021 4
20 Jan, 2021 4
20 Jan, 2021 4
20 Jan, 2021 4
20 Jan, 2021 4
20 Jan, 2021 4
20 Jan, 2021 4
20 Jan, 2021 4
12 Jan, 2021 4
12 Jan, 2021 SC 13D/A
6 Jan, 2021 4
5 Jan, 2021 8-K
Last update:2025-03-06 12:20:33.613814

Sign Up to Subscribe